5 related news articles for Immunohaematology
-
Shifting the dial in Myelodysplastic Syndromes (MDS) treatment
Our study is among the first to demonstrate a direct mechanistic link between dysregulated iron homeostasis and inflammasome-driven inflammation in MDS.… Read more
-
RNA offers hope for new Parkinson’s treatment
An RNA-based gene therapy treatment for Parkinson’s disease that could slow and possibly even stop the condition is now a big step closer.… Read more
-
Researchers develop viral gene therapy to treat beta thalassaemia
Hudson Institute researchers have developed a new gene therapy strategy to treat beta thalassaemia, an inherited disorder where the body doesn’t make enough haemoglobin in red blood cells. These disorders lead to altered production of both haemoglobin and red blood cells, causing serious life-threatening complications soon after birth. … Read more
-
Stunning NHMRC Grant success
Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.… Read more
-
VCA funding for Hudson Institute researchers
MIMR-PHI cancer researchers, Drs George Grigoriadis and Daniel Gough were among 25 scientists recently awarded VCA funding.… Read more